Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
Nucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents. For their ability to compete with physiological nucleosides, NAs act as antimetabolites exerting their activity by interfering with the s...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/941 |
_version_ | 1827748044675743744 |
---|---|
author | Federica De Castro Erika Stefàno Erik De Luca Michele Benedetti Francesco Paolo Fanizzi |
author_facet | Federica De Castro Erika Stefàno Erik De Luca Michele Benedetti Francesco Paolo Fanizzi |
author_sort | Federica De Castro |
collection | DOAJ |
description | Nucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents. For their ability to compete with physiological nucleosides, NAs act as antimetabolites exerting their activity by interfering with the synthesis of nucleic acids. Much progress in the comprehension of their molecular mechanisms has been made, including providing new strategies for potentiating anticancer/antiviral activity. Among these strategies, new platinum-NAs showing a good potential to improve the therapeutic indices of NAs have been synthesized and studied. This short review aims to describe the properties and future perspectives of platinum-NAs, proposing these complexes as a new class of antimetabolites. |
first_indexed | 2024-03-11T06:02:48Z |
format | Article |
id | doaj.art-f7486f30b5d54869bc94a68b9658e47c |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-11T06:02:48Z |
publishDate | 2023-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-f7486f30b5d54869bc94a68b9658e47c2023-11-17T13:16:33ZengMDPI AGPharmaceutics1999-49232023-03-0115394110.3390/pharmaceutics15030941Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and PerspectivesFederica De Castro0Erika Stefàno1Erik De Luca2Michele Benedetti3Francesco Paolo Fanizzi4Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyNucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents. For their ability to compete with physiological nucleosides, NAs act as antimetabolites exerting their activity by interfering with the synthesis of nucleic acids. Much progress in the comprehension of their molecular mechanisms has been made, including providing new strategies for potentiating anticancer/antiviral activity. Among these strategies, new platinum-NAs showing a good potential to improve the therapeutic indices of NAs have been synthesized and studied. This short review aims to describe the properties and future perspectives of platinum-NAs, proposing these complexes as a new class of antimetabolites.https://www.mdpi.com/1999-4923/15/3/941nucleoside analoguesplatinum compoundscoordination compoundsantitumor drugsantiviral drugsantimetabolites |
spellingShingle | Federica De Castro Erika Stefàno Erik De Luca Michele Benedetti Francesco Paolo Fanizzi Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives Pharmaceutics nucleoside analogues platinum compounds coordination compounds antitumor drugs antiviral drugs antimetabolites |
title | Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives |
title_full | Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives |
title_fullStr | Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives |
title_full_unstemmed | Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives |
title_short | Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives |
title_sort | platinum nucleos t ide compounds as possible antimetabolites for antitumor antiviral therapy properties and perspectives |
topic | nucleoside analogues platinum compounds coordination compounds antitumor drugs antiviral drugs antimetabolites |
url | https://www.mdpi.com/1999-4923/15/3/941 |
work_keys_str_mv | AT federicadecastro platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives AT erikastefano platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives AT erikdeluca platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives AT michelebenedetti platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives AT francescopaolofanizzi platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives |